Anti-NMDAR Encephalitis with Relapsing Optic Neuritis

被引：0
作者：
Belova A.N. [1 ]
Grygorieva V.N. [1 ]
Rasteryaeva M.V. [1 ]
Ruina E.A. [1 ]
Belova E.M. [2 ]
Solovieva V.S. [2 ]
Boyko A.N. [3 ,4 ]
机构：
[1] Privolzhsky Research Medical University, Russian Ministry of Health, Nizhny Novgorod
[2] City Clinical Hospital No. 3, Nizhny Novgorod
[3] Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow
[4] Federal Brain and Neurotechnology Center, Russian Federal Medical Biological Agency, Moscow
来源：
Neuroscience and Behavioral Physiology | 2021年 / 51卷 / 2期
关键词：
anti-NMDAR encephalitis; comorbidity; multiple sclerosis; optic neuritis; optic neuromyelitis spectrum disease;
D O I：
10.1007/s11055-021-01053-x
中图分类号：
学科分类号：
摘要：
Autoimmune encephalitis with antibodies to NMDA receptors (anti-NMDAR encephalitis) is a frequent form of autoimmune encephalitis. The disease is curable, though the lack of timely treatment can lead to disability in patients or death. Difficulties in the diagnosis of anti-NMDAR encephalitis arise from its heterogenous manifestations, its possible combination with other autoimmune diseases, and lack of doctors’ awareness of this type of encephalitis. This article reviews published data and describes a case of anti-NMDAR encephalitis with atypical features in the form of relapsing optic neuritis; it was difficult to link optic nerve lesions with comorbidity with multiple sclerosis or optic neuromyelitis spectrum disorders. © 2021, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码：163 / 170
页数：7
相关论文
共 59 条
  • [1] Vitaliani R., Mason W., Ances B., Et al., Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma, Ann. Neurol., 58, 4, pp. 594-604, (2005)
  • [2] Dalmau J., Tuzun E., Wu H., Masjuan J., Et al., Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma, Ann. Neurol., 61, 1, pp. 25-36, (2007)
  • [3] Graus F., Titulaer M.J., Balu R., Dalmau J., A clinical approach to diagnosis of autoimmune encephalitis, Lancet Neurol., 15, 4, pp. 391-404, (2016)
  • [4] Dalmau J., Lancaster E., Martinez-Hernandez E., Et al., Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, Lancet Neurol., 10, 1, pp. 63-74, (2011)
  • [5] Iizuka T., Sakai F., Ide T., Et al., Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal, Neurology, 70, 7, pp. 504-511, (2008)
  • [6] Tuzune E., Dalmau J., Limbic encephalitis and variants: classification, diagnosis and treatment, Neurologist, 13, 5, pp. 261-271, (2007)
  • [7] Gastaldi M., Nosadini M., Spatola M., Et al., N-methyl-D-aspartate receptor encephalitis: laboratory diagnostics and comparative clinical features in adults and children, Expert Rev. Mol. Diagn., 18, 2, pp. 181-193, (2018)
  • [8] Guasp M., Dalmau J., Encephalitis associated with antibodies against the NMDA receptor, Med. Clin. (Barc.), 151, 2, pp. 71-79, (2018)
  • [9] Titulaer M.J., Hoftberger R., Iizuka T., Et al., Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis, Ann. Neurol., 75, 3, pp. 411-428, (2014)
  • [10] Zoccarato M., Saddi M.V., Serra G., Et al., Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis, J. Neurol., 260, 12, pp. 3185-3187, (2013)
123456